BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27600388)

  • 1. Is peritoneal dialysis causing a measurable burden of inflammatory and endothelial injury on top of metabolic syndrome?
    Miler M; Nikolac N; Segulja D; Kackov Maslac S; Celap I; Altabas K; Sefer S; Simundic AM
    J Endocrinol Invest; 2017 Feb; 40(2):163-168. PubMed ID: 27600388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
    Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
    Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients.
    Choi HY; Lee JE; Han SH; Yoo TH; Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Nephrol Dial Transplant; 2010 Apr; 25(4):1266-71. PubMed ID: 19926717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
    Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
    Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations.
    Heggen E; Klemsdal TO; Haugen F; Holme I; Tonstad S
    Metab Syndr Relat Disord; 2012 Dec; 10(6):437-42. PubMed ID: 22889406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin and endothelial function in dialyzed patients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Nephrology (Carlton); 2010 Mar; 15(2):190-6. PubMed ID: 20470278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
    Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
    Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of carbohydrate versus fat restriction on serum levels of adipocytokines, markers of inflammation, and endothelial function among women with the metabolic syndrome: a randomized cross-over clinical trial.
    Rajaie S; Azadbakht L; Saneei P; Khazaei M; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):159-67. PubMed ID: 24021709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors.
    Roberts CK; Won D; Pruthi S; Kurtovic S; Sindhu RK; Vaziri ND; Barnard RJ
    J Appl Physiol (1985); 2006 May; 100(5):1657-65. PubMed ID: 16357066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome.
    Schindler K; Vila G; Hoppichler F; Lechleitner M; Luger A; Anderwald C; Hoefler J; Tomasec G; Kautzky-Willer A; Ludvik B
    Obes Facts; 2012; 5(2):270-6. PubMed ID: 22647307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to Fine Particulate Air Pollution Is Associated With Endothelial Injury and Systemic Inflammation.
    Pope CA; Bhatnagar A; McCracken JP; Abplanalp W; Conklin DJ; O'Toole T
    Circ Res; 2016 Nov; 119(11):1204-1214. PubMed ID: 27780829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased RhoA/Rho-Kinase Activity and Markers of Endothelial Dysfunction in Young Adult Subjects with Metabolic Syndrome.
    Leguina-Ruzzi A; Pereira J; Pereira-Flores K; Valderas JP; Mezzano D; Velarde V; Sáez CG
    Metab Syndr Relat Disord; 2015 Nov; 13(9):373-80. PubMed ID: 26512756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction.
    Bo S; Gambino R; Durazzo M; Ghione F; Musso G; Gentile L; Cassader M; Cavallo-Perin P; Pagano G
    J Endocrinol Invest; 2008 Jun; 31(6):499-504. PubMed ID: 18591880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketoacid Supplementation Partially Improves Metabolic Parameters in Patients on Peritoneal Dialysis.
    Dong J; Li YJ; Xu R; Ikizler TA; Wang HY
    Perit Dial Int; 2015 Dec; 35(7):736-42. PubMed ID: 26374833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
    Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
    Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokines, hepatocyte growth factor and adipokines in peritoneal dialysis patients.
    Lee CT; Ng HY; Hsu CY; Tsai YC; Yang YK; Chen TC; Chiou TT; Kuo CC; Lee WC; Hsu KT
    Artif Organs; 2010 Jul; 34(7):E222-9. PubMed ID: 20545663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.